Lichen International (LICN) Common Equity (2021 - 2025)
Lichen International (LICN) posted quarterly Common Equity of $70.6 million for Q4 2025, down 6.64% year-over-year from $75.6 million in Q4 2024, and up 9.8% quarter-over-quarter from $64.3 million in Q2 2025.
Lichen International (LICN) Common Equity (2021 - 2025) Analysis & Trends
Lichen International (LICN) has reported Common Equity for 5 consecutive years, with $70.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 6.64% year-over-year to $70.6 million; the TTM figure through Dec 2025 stood at $70.6 million (down 6.64% YoY), while the FY2025 annual figure was $70.6 million, down 6.64% from the prior year.
- Common Equity improved to $70.6 million in Q4 2025 per LICN's latest filing, from $64.3 million in the prior quarter.
- Across five years, Common Equity topped out at $75.6 million in Q4 2024 and bottomed at $36.8 million in Q4 2021.
- Historically, Common Equity has averaged $59.1 million across 5 years, with a median of $62.8 million in 2023.
- Annual changes were most pronounced in 2023 — Common Equity surged 49.41% — and 2025, when it fell 7.93%.
- Lichen International's Common Equity stood at $36.8 million in 2021, then gained by 11.61% to $41.1 million in 2022, then jumped by 49.41% to $61.4 million in 2023, then gained by 23.03% to $75.6 million in 2024, then decreased by 6.64% to $70.6 million in 2025.
- Business Quant data shows LICN's Common Equity at $70.6 million in Q4 2025, $64.3 million in Q2 2025, and $75.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.69 Bn | 81.40 Bn | 1.48 Bn | 5.14 Bn |
| 2 | Relx | 64.97 Bn | 64.80 Bn | - | 3.18 Bn |
| 3 | Copart | 32.09 Bn | 28.74 Bn | 732.88 Mn | 8.77 Bn |
| 4 | Global Payments | 24.80 Bn | 19.40 Bn | 2.03 Bn | 23.76 Bn |
| 5 | Rb Global | 16.24 Bn | 15.72 Bn | 935.50 Mn | 5.57 Bn |
| 6 | Aramark | 15.68 Bn | 15.18 Bn | 430.34 Mn | 3.39 Bn |
| 7 | UL Solutions | 15.20 Bn | 14.77 Bn | 417.00 Mn | 1.62 Bn |
| 8 | Rentokil Initial | 11.80 Bn | 9.27 Bn | - | - |
| 9 | Dolby Laboratories | 6.05 Bn | 5.38 Bn | 264.68 Mn | 2.59 Bn |
| 10 | Lichen International | 6.63 Mn | -20.29 Mn | - | 70.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 70.55 Mn |
| Jun 30, 2025 | 64.25 Mn |
| Dec 31, 2024 | 75.57 Mn |
| Jun 30, 2024 | 69.78 Mn |
| Dec 31, 2023 | 61.42 Mn |
| Jun 30, 2023 | 53.28 Mn |
| Dec 31, 2022 | 41.11 Mn |
| Dec 31, 2021 | 36.83 Mn |